Arsenal Capital Partners

Arsenal Capital Partners recently hosted scholars from BLK Capital Management, Corp at our offices here in NYC. This event provided scholars with professional development opportunities in addition to valuable insights into private equity. Arsenal’s partnership with BLK Capital Management demonstrates both organizations’ commitment to advancing diversity and mentorship within the finance sector and supporting students as they build critical skills for future careers in finance and investing. We can’t wait to see what the future holds for these future business leaders!

Excited for next week!

We are pleased to welcome Joshua Schultz to Arsenal. Joshua joins as an Operating Partner within the firm’s healthcare team and will focus on pharma services and medical technology investment strategies and portfolio companies. Joshua was most recently the CEO of Cytel, an industry leader in advanced analytics for the life sciences industry. Over a five-year period from 2019 to 2024, he led Cytel and transformed the company from a well-regarded statistical software and consulting firm into a fully scaled analytics company with software and services used by over 500 life sciences customers, including the world's top 30 pharmaceutical companies, and more than 1,500 employees globally. For more information, please see a copy of the press release here: https://lnkd.in/eQehiXUQ

We're thrilled to announce the appointment of Michael Jackman as 3DR's new Chief Executive Officer ("CEO"), effective today, November 4, 2024. Mr. Jackman brings more than four decades of experience to this role, having most recently served as the Chief Operating Officer (“COO”) of Leidos Health Group, a $3 billion subsidiary of Fortune 500 science and technology leader, Leidos Holdings, Inc. (NYSE: LDOS). Prior to joining Leidos, he served as an operating partner at Ardan Equity Partners where he collaborated with founders and management teams to build differentiated healthcare enterprise platforms. Before that, Mr. Jackman was CEO of Mach7 Technologies and served as the Americas Region CEO for GE Healthcare’s Digital HCIT Division. “I am thrilled to join 3DR Labs as its new CEO. The company sits at the forefront of AI-powered imaging translation and analytics solutions, and I believe our team can continue to stay on the cutting edge,” said Mr. Jackman. “Together, we will shape the future of visual data and bring innovative solutions to our clients.” https://hubs.la/Q02WNb8j0 #MedicalImaging #ImagingSolutions #Radiology #Healthcare #PressRelease

Earlier this week, Patricia Grad, Partner and Head of Investor Relations, guest lectured at Columbia Business School's “PE Allocation” course. Returning as an alumna, Patricia shared her perspectives on private equity fundraising, providing valuable insights and real-world experiences to the next generation of private equity professionals. A huge thank you to Columbia Business School Private Equity Program, Professor Michael Ewens, and Professor Kevin Lu for the invitation!

Our very own Joelle Marquis, President of Arsenal Capital Partners, sat down with Sean Mooney on BluWave's Karma School of Business Podcast to explore: ? Her entry into private equity and her career growth ? Arsenal's culture of genuine partnership and servant leadership ? Differentiating human resources and human capital ? The strategic vision and leadership that is shaping the future of private equity Tune in to the full conversation on your preferred streaming platform or via the link in the comments below. #PrivateEquity #Leadership #Podcast #KarmaSchoolOfBusiness

Last week, we held our 2024 Annual Investor Meeting in New York City. We had the opportunity to discuss the level of change and innovation occurring in our markets and highlight our work to develop strategies and build market-leading companies. Thank you to all our investors who joined us both in person and online, and to our Arsenal team members who showcased how we plan to build for tomorrow.?

Today we announced the formation of our Digital and AI Advisory Board. The formation demonstrates Arsenal’s long-standing commitment, leadership, and focus on core sciences with data capabilities. Arsenal’s Digital and AI Advisory Board is comprised of world-renowned luminaries in the biomedical data science field, including Dr. Amy Abernethy, Dr. Junaid Bajwa, and Dr. Nigam Shah. Dr. Dimitris K. Agrafiotis, Director of Digital, Analytics, and AI of Arsenal and co-chair of the Digital and AI Advisory Board, said, “Amy, Junaid, and Nigam have had an outsized impact on the field of biomedical informatics and have been uniquely able to translate theory to practice, and then practice to routine use. Their piercing intellect, pragmatic mindset, and deep understanding of healthcare will be invaluable in our efforts to advance our understanding of human biology and address long-lasting inefficiencies in the healthcare system.” The full press release can be found here: https://lnkd.in/d4BjgfMX

Press Release: ATP Adhesive Systems AG acquires Neschen Coating GmbH from Blue Cap AG to Enhance Capacity and Sustainability Wollerau, Switzerland, 7th of October 2024 ? ? ATP adhesive systems AG (ATP), a global leader in solvent-free adhesive technologies, proudly announces the acquisition of NESCHEN Coating GmbH (NESCHEN), a well-established manufacturer of solvent-free adhesive products, from Blue Cap AG. This strategic acquisition is a pivotal step in ATP’s mission to enhance production capacity, further its commitment to sustainable products, and strengthen its supply chain resiliency. ? The acquisition of NESCHEN aligns with ATP’s long-term strategy of delivering innovative, solvent-free solutions to its customers across various industries. Both companies share a strong focus on sustainability, as NESCHEN, like ATP, is dedicated to producing eco-friendly, solvent-free adhesives and products thereof. This shared vision ensures a seamless integration of NESCHEN COATING GMBH into the ATP family and reinforces ATP's position as a market leader in environmentally responsible adhesive technologies. ? Expansion of the Graphic Arts Product Portfolio and Capacity Enhancement With NESCHEN’s advanced production capabilities, ATP significantly increases its manufacturing capacity, enabling higher production volumes and improved operational efficiency. This acquisition also facilitates strategic diversification, allowing ATP to tap into new markets and broaden its product offerings, particularly within the graphic arts segment and other key sectors. In addition to expanding production, the acquisition fortifies ATP’s supply chain strategy, ensuring operational resilience and redundancy. ?By incorporating NESCHEN’s assets and capabilities, ATP enhances its ability to respond quickly to market demands and potential disruptions, ensuring uninterrupted service for its global customer base. ? A Step Forward in Sustainability NESCHEN’s expertise in producing solvent-free adhesive products perfectly complements ATP’s core focus on sustainability. This acquisition strengthens ATP's position as a leader in eco-friendly adhesive technologies, aligning with the increasing demand for sustainable products across industries such as automotive, construction, and medical. ? Quote from ATP Leadership: "We are thrilled to welcome NESCHEN into the ATP family. This acquisition is not just about increasing our production capacity, but also about advancing our shared commitment to sustainability. Together, we will continue to lead the market with innovative, solvent-free solutions," said Heini Daniel, CEO of the ATP Group. ? ? ?

At Arsenal Capital Partners, we thrive on collaboration, innovation, and growth. We are excited to welcome our latest class of associates, who bring fresh perspectives and exceptional talents. Together, we will continue to drive transformative results and build strategically important companies. We look forward to the contributions and achievements that they will bring! #Welcome #PrivateEquity #Talent #ArsenalCapitalPartners